Table 2: Demographic characteristics of study participants.
| Characteristics | Chemotherapy N = 31 (%) | Integrated therapy N = 30 (%) | p |
| Age (years) | |||
| Mean value ± SD | 64.1 (9.8) | 49.2 (11.6) | 0.000*** |
| Gender | N (%) | N (%) | |
| Male | 21 (67.7) | 9 (30.0) | 0.005** |
| Female | 10 (32.3) | 21 (70.0) | |
| Cancer diagnosis | N (%) | N (%) | |
| Gastrointestinal tract | 17 (54.8) | 7 (23.3) | 0.029* |
| Breast | 2 (6.5) | 12 (40.0) | |
| Lung | 3 (9.7) | 4 (13.3) | |
| Head & Neck | 1 (3.2) | 2 (6.7) | |
| GU and GYN | 3 (9.7) | 2 (6.7) | |
| Others | 5 (16.1) | 3 (10.0) | |
| ECOG score | N (%) | N (%) | |
| 0 | 5 (16.1) | 10 (33.3) | 0.296 |
| 1 | 17 (54.8) | 13 (43.3) | |
| 2 | 9 (29.0) | 7 (23.3) | |
| Current treatment | N (%) | N (%) | |
| Curative treatment | 22 (71.0) | 19 (63.3) | 0.359 |
| Palliative treatment | 9 (29.0) | 11 (36.7) |
***p < 0.001; **p < 0.01; *p < 0.05.